Efficacy and safety of Yttrium 90 (90Y) ibritumomab tiuxetan in autologous and nonmyeloablative stem cell transplantation (NST) for relapsed non-Hodgkin's lymphoma (NHL).

被引：7

作者：

Khouri, Issa F. ^{[1
]}

Saliba, Rima M. ^{[1
]}

Hosing, Chitra ^{[1
]}

Valverde, Rosamar ^{[1
]}

Erwin, William D. ^{[1
]}

Fayad, Luis ^{[1
]}

Maadani, Farzaneh ^{[1
]}

Korbling, Martin J. ^{[1
]}

Okoroji, Grace-Julia ^{[1
]}

Stachowiak, Anne M. ^{[1
]}

Samuels, Barry I. ^{[1
]}

Anderlini, Paolo ^{[1
]}

Couriel, Daniel R. ^{[1
]}

de Lima, Marcos ^{[1
]}

Giralt, Sergio ^{[1
]}

Popat, Uday ^{[1
]}

Kebriaei, Partow ^{[1
]}

Ueno, Naoto T. ^{[1
]}

Qazilbash, Muzaffar H. ^{[1
]}

McLaughlin, Peter W. ^{[1
]}

Hagemeister, Fredrick B. ^{[1
]}

Younes, Anas ^{[1
]}

Podoloff, Donald A. ^{[1
]}

Champlin, Richard E. ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

BLOOD | 2006年 / 108卷 / 11期

关键词：

D O I：

10.1182/blood.V108.11.315.315

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

315

引用

页码：98A / 98A

页数：1

共 50 条

[21] 90Y-Ibritumomab Tiuxetan as Consolidation Therapy After Autologous Stem Cell Transplantation in Aggressive Non-Hodgkin Lymphoma
Ria, Roberto
Musto, Pellegrino
Reale, Antonia
Guariglia, Roberto
Iodice, Giuseppe
Dammacco, Franco
Vacca, Angelo
JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (06) : 891 - 895
[22] Radioimmunotherapy with 90Y Ibritumomab Tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
Palumbo, B.
Sabalich, I.
Falcinelli, F.
Capponi, M.
Martelli, M.
Palumbo, R.
Sinzinger, H.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S419 - S419
[23] Feasibility of yttrium 90 (90Y) ibritumomab tiuxetan (Zevalin®) radioimmunotherapy for non-Hodgkin's lymphoma in a patient with chronic renal failure.
Spies, SM
Gordon, LI
Zimmer, AM
Cutrera, P
BLOOD, 2004, 104 (11) : 244B - 244B
[24] Experience on Therapy with 90Y Ibritumomab Tiuxetan in Relapsed/Refractory Non-Hodgkin Lymphoma. Analysis of Outcomes
Baringo, T.
Giraldo, P.
Lievano, P.
Navarro, P.
Arroyo, E.
Ananos, M.
de la Cueva, L.
Abos, D.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S352 - S352
[25] Radioimmunotherapy with 90Y ibritumomab tiuxetan in refractory/relapsed follicular non-hodgkin lymphoma results in an Spanish center
Rubio-Martinez, A.
Agustin, M. J.
Recasens, V.
Lopez-Gomez, L.
Perella, M.
Perez-Lungmus, G.
Baringo, T.
Giraldo, P.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 418 - 418
[26] Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma
McKinney, Matthew S.
Beaven, Anne W.
BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2014, 4 : 45 - 59
[27] Autologous Transplantation for Transformed Non-Hodgkin Lymphoma Using an Yttrium-90 Ibritumomab Tiuxetan Conditioning Regimen
Mei, Matthew
Wondergem, Marielle J.
Palmer, Joycelynne M.
Shimoni, Avichai
Hasenkamp, Justin
Tsai, Ni-Chun
Simpson, Jennifer
Nademanee, Auayporn
Raubitschek, Andrew
Forman, Stephen J.
Krishnan, Amrita Y.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (12) : 2072 - 2075
[28] Efficacy of 90Y ibritumomab-tiuxetan treatment in a case of resistant gastric MALT non-Hodgkin's lymphoma
Ferruccil, P. F.
Vanazzi, A.
Crosta, C.
Pruneri, G.
Grana, C.
Bartolomei, M.
Paganelli, G.
Martinelli, G.
ECANCERMEDICALSCIENCE, 2008, 2
[29] Use of 90Y-ibritumomab tiuxetan in non-Hodgkin's lymphoma
Marcus, R
SEMINARS IN ONCOLOGY, 2005, 32 (01) : S36 - S43
[30] 90Yttrium-ibritumomab tiuxetan:: a novel treatment for non-Hodgkin's lymphoma
Blum, KA
Bartlett, NL
EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (08) : 1323 - 1331

← 1 2 3 4 5 →